Jeff Yass’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Other funds holding TARA
BBA
ACA
Jeff Yass's TARA Position: Q3 2026 in Review
Jeff Yass reduced its Protara Therapeutics (TARA) stake by 61% in Q3 2026, selling an estimated $96.5K and leaving 15,614 shares worth $47.6K. The position accounts for ﹤0.01% of the portfolio, ranked #12904.
Jeff Yass first reported a position in TARA in Q1 2017 and has held it in 23 quarters since. The position peaked at $1.17M in Q1 2025. 119 funds tracked by Wall St. Rank hold TARA as of Q3 2026.
- Jeff Yass held 15,614 shares of Protara Therapeutics worth $47.6K as of Q3 2026.
- Jeff Yass sold 24,766 Protara Therapeutics shares in Q3 2026, an estimated $96.5K.
- Protara Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12904 holding.
- Jeff Yass first reported a position in Protara Therapeutics in Q1 2017 and has held it in 23 quarters since.
- Jeff Yass's Protara Therapeutics position peaked at $1.17M in Q1 2025.
- 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.